Thursday's Winners & Losers: RIM

BlackBerry maker RIM(RIMM Quote - Cramer on RIMM - Stock Picks) gained $7.06, or 6.1%, to $122.80 after the company blew past analysts' estimates for the fourth quarter and guided higher than expectations for the current quarter. Net income for the fourth quarter jumped 120% to $412.5 million, or 72 cents a share, while revenue rose 102% to $1.88 billion.

Analysts polled by Thomson Financial were expecting revenue of $1.85 billion and earnings of 70 cents a share. For the current quarter, RIM forecast revenue in the range of $2.23 billion to $2.3 billion, and EPS in the range of 82 cents to 86 cents -- higher than analysts' consensus of $2 billion in sales and EPS of 75 cents.

Meanwhile, investors granted Schering-Plough (SGP Quote - Cramer on SGP - Stock Picks) shares a bit of relief, reacting positively to a $1.5 billion cost-cutting plan. Shares rose $1.49, or 10.8%, to $15.35.

Shares of Syntax-Brillian (BRLC Quote - Cramer on BRLC - Stock Picks), a Tempe, Ariz.-based maker of high-definition TVs, jumped 16% to $1.23. The company announced a partnership with Compal Electronics, under which Compal will fill an initial manufacturing order of 300,000 televisions in its Chinese facility. Syntax-Brillian CEO James Li said that the move was key to the company's cost-reduction and cash flow-improvement efforts.

Access Integrated Tech (AIXD Quote - Cramer on AIXD - Stock Picks) climbed 18.5% to $3.85. The Morristown, N.J.-based provider of integrated solutions for digital cinema announced it had extended the employment contract of CEO A. Dale Mayo through March 31, 2011.

Semiconductor company MEMC Electronic Materials(WFR Quote - Cramer on WFR - Stock Picks) fell $2.61, or 3.4%, to $73.83 after the company lowered its first-quarter revenue outlook. MEMC said it expects revenue of about $500 million and gross margin of 52%, compared with its earlier forecast of $560 million and gross margin of 54.2%.

Elsewhere, AngioDynamics (ANGO Quote - Cramer on ANGO - Stock Picks) rose $1.26, or 11%, to $12.81 Thursday after earnings and settlement news.

The company said it reached an agreement with Diomed to resolve a patent infringement lawsuit dating back to January 2004. As a result, AngioDynamics said it decreased its litigation provision and also recorded a net after-tax gain of $2 million, and 8 cents a share in its third quarter.

For the quarter -- including the settlement -- the company earned $4.8 million, or 20 cents a share. Analysts surveyed by Thomson Financial had predicted 12 cents a share.